Preferred Label : factor xa;
MeSH definition : Activated form of factor X that participates in both the intrinsic and extrinsic pathways
of blood coagulation. It catalyzes the conversion of prothrombin to thrombin in conjunction
with other cofactors.;
MeSH synonym : factor x, activated; coagulation factor xa; autoprothrombin c; factor xa, coagulation; thrombokinase; activated factor x; blood coagulation factor x, activated; Factor Ten A; Factor 10A;
CISMeF synonym : xa, coagulation factor;
Registry Number MeSH : EC 3.4.21.6;
MeSH annotation : /defic FACTOR X DEFICIENCY;
Wikipedia link : https://en.wikipedia.org/wiki/Thrombokinase;
Is substance : O;
UNII : EC 3.4.21.6;
Origin ID : D015951;
UMLS CUI : C0015520;
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Indexing information
- DPC 602 [MeSH Supplementary Concept]
- FX 2212 [MeSH Supplementary Concept]
- SE 170 [MeSH Supplementary Concept]
- SF 324 [MeSH Supplementary Concept]
- lefaxin [MeSH Supplementary Concept]
Record concept(s)
Related MeSH Supplementary Concept(s)
Related MeSH term(s)
See also
See also (suggested by CISMeF)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT
Activated form of factor X that participates in both the intrinsic and extrinsic pathways
of blood coagulation. It catalyzes the conversion of prothrombin to thrombin in conjunction
with other cofactors.
https://www.ema.europa.eu/en/medicines/human/EPAR/ondexxya
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
andexanet alfa
andexanet alfa
hemorrhage
hemorrhage
apixaban
Rivaroxaban
antidotes
antidotes
adult
infusions, intravenous
Factor Xa Inhibitors
andexanet alfa
product surveillance, postmarketing
pregnancy
breast feeding
Anticoagulant reversal therapy
PRT064445
PRT064445
recombinant proteins
factor xa
recombinant proteins
factor xa
pyrazoles
pyridones
---
https://www.revmed.ch/RMS/2014/RMS-N-416/Pourquoi-quand-et-comment-doser-les-nouveaux-anticoagulants-oraux
2014
false
false
false
Switzerland
French
journal article
thromboembolism
continuity of patient care
drug monitoring
anticoagulants
administration, oral
rivaroxaban
apixaban
dabigatran etexilate
apixaban
risk factors
blood coagulation tests
kidney failure, chronic
factor xa
antithrombins
Factor Xa Inhibitors
Rivaroxaban
Dabigatran
pyrazoles
pyridones
---
https://www.revmed.ch/RMS/2014/RMS-N-416/Gestion-peri-interventionnelle-des-nouveaux-anticoagulants-oraux-directs
2014
false
false
false
Switzerland
French
journal article
administration, oral
anticoagulants
factor xa
perioperative care
postoperative hemorrhage
blood loss, surgical
anticoagulants
apixaban
antithrombins
antithrombins
Factor Xa Inhibitors
Therapy cessation
anticoagulotherapy
Dabigatran
Rivaroxaban
pyrazoles
pyridones
---
https://www.revmed.ch/RMS/2014/RMS-N-416/Nouveaux-anticoagulants-oraux-donnees-pharmacologiques-a-connaitre-pour-la-pratique-clinique
2014
false
false
false
Switzerland
French
journal article
anticoagulants
administration, oral
antithrombins
factor xa
apixaban
thromboembolism
thromboembolism
drug interactions
renal insufficiency
hepatic insufficiency
aged
obesity
anticoagulants
antithrombins
Factor Xa Inhibitors
anticoagulotherapy
Rivaroxaban
Dabigatran
pyrazoles
pyridones
---
http://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Medicaments/INESSS_outil_choix_anticoagulotherapie.pdf
2012
false
true
false
Canada
factor xa
anticoagulants
anticoagulants
anticoagulants
anticoagulants
Rivaroxaban
technical report
atrial fibrillation
adult
---
https://www.jle.com/fr/revues/nro/e-docs/les_inhibiteurs_du_facteur_xa_289391/article.phtml
2010
false
France
French
Factor Xa Inhibitors
Rivaroxaban
journal article
factor xa
atrial fibrillation
DERMATITIS
fibrinolytic agents
stroke
edoxaban
apixaban
pyrazoles
pyridones
pyridines
thiazoles
Direct factor Xa inhibitors
---